Semaglutide Subcutaneous Injection
  1. Home
  2. Wegovy
  3. Semaglutide Subcutaneous Injection

Semaglutide Subcutaneous Injection

Semaglutide Subcutaneous Injection is a prescription GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is administered as a once-weekly subcutaneous injection using a prefilled pen. The injectable formulation provides effective long-term metabolic management when combined with diet and exercise.

BUY NOW

Category

Semaglutide Subcutaneous Injection contains semaglutide, a GLP-1 receptor agonist that helps regulate blood glucose by stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety. The once-weekly subcutaneous formulation offers consistent therapeutic delivery and is widely used for the management of type 2 diabetes and selected weight management programs. Manufactured under stringent pharmaceutical quality standards, it is supplied in sterile prefilled injection pens designed for accurate and convenient dose administration. Semaglutide Subcutaneous Injection should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Semaglutide Subcutaneous Injection
Active Ingredient Semaglutide
Dosage Form Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly (As Prescribed)
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Semaglutide Subcutaneous Injection, Semaglutide Injection, GLP-1 Receptor Agonist Injection, Weekly Semaglutide Injection, Semaglutide Prefilled Pen, Diabetes Injection Pen, Weight Management Injection